iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Sees Significant Growth in Short Interest

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 10,041 shares, an increase of 150.8% from the November 30th total of 4,003 shares. Based on an average daily volume of 15,724 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.7% of the shares of the stock are sold short. Currently, 0.7% of the shares of the stock are sold short. Based on an average daily volume of 15,724 shares, the days-to-cover ratio is currently 0.6 days.

iShares LifePath Target Date 2045 ETF Trading Up 0.2%

ITDE stock traded up $0.06 during mid-day trading on Friday, reaching $36.51. The company’s stock had a trading volume of 4,993 shares, compared to its average volume of 10,345. The company’s 50 day moving average is $36.40 and its two-hundred day moving average is $35.19. iShares LifePath Target Date 2045 ETF has a fifty-two week low of $27.42 and a fifty-two week high of $36.96. The stock has a market cap of $49.65 million, a PE ratio of 20.03 and a beta of 0.82.

Hedge Funds Weigh In On iShares LifePath Target Date 2045 ETF

A number of institutional investors have recently added to or reduced their stakes in ITDE. Susquehanna International Group LLP boosted its stake in iShares LifePath Target Date 2045 ETF by 38.4% during the third quarter. Susquehanna International Group LLP now owns 9,001 shares of the company’s stock worth $323,000 after buying an additional 2,496 shares during the last quarter. Sunbelt Securities Inc. boosted its position in shares of iShares LifePath Target Date 2045 ETF by 2,054.5% during the 3rd quarter. Sunbelt Securities Inc. now owns 2,607 shares of the company’s stock valued at $94,000 after acquiring an additional 2,486 shares during the last quarter. Finally, Geneos Wealth Management Inc. acquired a new position in shares of iShares LifePath Target Date 2045 ETF during the 1st quarter valued at about $34,000.

iShares LifePath Target Date 2045 ETF Company Profile

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.